Erasca

Ruga, the leading company targeting endoplasmic reticulum (ER) stress in cancer and other indications, is advancing small molecules from discovery to clinical proof of concept in multiple myeloma and renal cell carcinoma, and is developing a platform for the identification of new and existing drugs ...